Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations

Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations

The interaction between programmed cell death protein 1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) induces exhaustions of cytotoxic lymphocytes in the tumor microenvironment, which facilitates tumor immune evasion. PD-1/PD-L1 blockade therapy, which prevents the receptors and ligands fr...

Full description

Bibliographic Details
Main Authors: Jiqiao Yang, Xiujing He, Qing Lv, Jing Jing, Hubing Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Pharmacology
Subjects:
programmed cell death protein 1
programmed death-ligand 1
adverse event
Asian
cancer
immunotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00726/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00726/full

Similar Items